{"id":477421,"date":"2026-02-19T07:46:09","date_gmt":"2026-02-19T07:46:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/477421\/"},"modified":"2026-02-19T07:46:09","modified_gmt":"2026-02-19T07:46:09","slug":"johnson-johnson-announces-1-billion-investment-in-new-facility-in-lower-gwynedd","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/477421\/","title":{"rendered":"Johnson &#038; Johnson announces $1 billion investment in new facility in Lower Gwynedd"},"content":{"rendered":"<p>Johnson &amp; Johnson\u00a0announced on February 18th a more than $1 billion investment in a next generation cell therapy manufacturing facility on a 154-acre property at 1201 Sumneytown Pike in Spring House (Lower Gwynedd). According to the announcement, \u201cThis new facility will further expand the Company\u2019s U.S. manufacturing capacity as it advances its industry leading portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases.\u201d<\/p>\n<p>\u201cFor 140 years,\u00a0Johnson &amp; Johnson\u00a0has been a leading innovator in American healthcare, and we are honored to continue advancing that legacy in Pennsylvania,\u201d said Joaquin Duato, chairman and chief executive officer of\u00a0Johnson &amp; Johnson. \u201cBy uniting scientific excellence with state-of-the-art manufacturing and strategic investment, and by working collaboratively with our communities, we are delivering for patients and creating significant opportunities for workers and families.\u201d<\/p>\n<p>According to Johnson and Johnson, the facility is expected to create 4,000 jobs during the construction phase and 500 skilled biomanufacturing jobs once open. Johnson &amp; Johnson is no stranger to Spring House, it has an existing facility in the community that employs 2,500 people. <\/p>\n<p>\u201cPennsylvania is a powerhouse for innovation and manufacturing in the life sciences,\u201d said Governor Josh Shapiro. \u201cJust a few years ago we weren\u2019t even on the field \u2013 but today we\u2019re competing and winning. We\u2019ve done it by creating the first economic development plan for Pennsylvania in 2 decades, and following through on it by cutting red tape, making strategic investments in key industries like the life sciences, and strengthening our workforce. That\u2019s why companies like\u00a0Johnson &amp; Johnson\u00a0are choosing to double down on their investments here in our Commonwealth \u2013 because they know we\u2019ve got the strategy, the workforce, and the speed they need to succeed.\u201d<\/p>\n<p>What Pennsylvania\u2019s politicians are saying:<\/p>\n<p>\u201cPennsylvania leads in life sciences and advanced manufacturing because we consistently deliver what companies like\u00a0Johnson &amp; Johnson\u00a0need to succeed: a skilled workforce, premier research institutions, and proven manufacturing strength,\u201d said U.S. Senator Dave McCormick. \u201cThis $1 billion-plus investment in a new Lower Gwynedd facility is a testament to that leadership and will produce life-changing treatments for patients, along with new and good jobs for our Commonwealth.\u201d<\/p>\n<p>\u201cPennsylvania is a leader in health care innovation with some of the very best health care workers. Proud to see this more than $1 billion investment into Montgomery County and our Commonwealth,\u201d said U.S. Senator John Fetterman. \u201cBringing new jobs, advanced manufacturing, and life-saving medicine to and for our communities is always something to celebrate.\u201d<\/p>\n<p>\u201cOur region is home to world-class healthcare, science and research \u2014 and the opening of\u00a0Johnson &amp; Johnson\u2019s cell therapy manufacturing facility in Lower Gwynedd expands its long tradition of leadership in Pennsylvania,\u201d Representative Madeleine Dean said. \u201cJ&amp;J\u2019s new site will promote job growth, foster innovation, and, most importantly, bring life-saving medicine to people around the country. I look forward to their continued success.\u201d<br \/>Image: Johnson &amp; Johnson<\/p>\n","protected":false},"excerpt":{"rendered":"Johnson &amp; Johnson\u00a0announced on February 18th a more than $1 billion investment in a next generation cell therapy&hellip;\n","protected":false},"author":2,"featured_media":477422,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[97,252,253],"class_list":["post-477421","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-health","tag-health-care","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/477421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=477421"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/477421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/477422"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=477421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=477421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=477421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}